Literature DB >> 17584487

Changes in ventricular dimensions and function during recovery of atrial tachycardia-induced cardiomyopathy treated with catheter ablation.

Leonard Ilkhanoff1, Edward P Gerstenfeld, Erica S Zado, Francis E Marchlinski.   

Abstract

A 25-year-old male with an atrial tachycardia-induced cardiomyopathy (TIC) presented to our institution with clinical heart failure, an ejection fraction of 10%, and a severely dilated left ventricle. He underwent successful ablation and had no recurrence of this arrhythmia. In this report, we document the acute and long-term follow-up (out to 10 years) of a single patient with a TIC and present the changes in left ventricular (LV) function and dimensions that occurred. Despite the apparent success of ablative therapy, this case report highlights the importance of routine clinical and echocardiographic follow-up in patients with longstanding TIC.

Entities:  

Mesh:

Year:  2007        PMID: 17584487     DOI: 10.1111/j.1540-8167.2007.00811.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Arrhythmia-Induced Cardiomyopathy: Prevalent, Under-recognized, Reversible.

Authors:  Rahul Dhawan; Rakesh Gopinathannair
Journal:  J Atr Fibrillation       Date:  2017-10-31

Review 2.  Arrhythmia-Induced Cardiomyopathy.

Authors:  Samuel Sossalla; Dirk Vollmann
Journal:  Dtsch Arztebl Int       Date:  2018-05-11       Impact factor: 5.594

Review 3.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 4.  Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

Authors:  Rakesh Gopinathannair; Susan P Etheridge; Francis E Marchlinski; Francis G Spinale; Dhanunjaya Lakkireddy; Brian Olshansky
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

5.  Electrophysiologic characteristics and catheter ablation results of tachycardia-induced cardiomyopathy in children with structurally normal heart.

Authors:  Hasan Candaş Kafalı; Erkut Öztürk; Senem Özgür; Gülhan Tunca Şahin; Alper Güzeltaş; Yakup Ergül
Journal:  Anatol J Cardiol       Date:  2020-12       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.